ceftolozane-tazobactam
Better Tools for Fighting Gram-Negative Infections, but More Are Needed
Multidrug-resistant gram-negative bacteria are difficult to treat, but FDA approvals have increased the clinical ...
FEBRUARY 27, 2025
Looking at 2 Antimicrobials for Drug-Resistant Pseudomonas aeruginosa
The purpose of this review is to discuss the in vitro activity and real-world evidence of ceftolozane-tazobactam ...
FEBRUARY 26, 2025
Merck to Seek New Indication for Zerbaxa
Zerbaxa is being studied for hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia ...
SEPTEMBER 18, 2018
Load more